Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - IDENIX PHARMACEUTICALS INC | c07238e10vq.htm |
| EX-31.1 - EX-31.1 SECTION 302 CERTIFICATION OF CEO - IDENIX PHARMACEUTICALS INC | c07238exv31w1.htm |
| EX-32.1 - EX-32.1 SECTION 906 CERTIFICATION OF CEO - IDENIX PHARMACEUTICALS INC | c07238exv32w1.htm |
| EX-10.1 - EX-10.1 AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT - IDENIX PHARMACEUTICALS INC | c07238exv10w1.htm |
| EX-10.2 - EX-10.2 SUBSIDIARIES OF THE COMPANY - IDENIX PHARMACEUTICALS INC | c07238exv10w2.htm |
| EX-31.2 - EX-31.2 SECTION 302 CERTIFICATION OF CFO - IDENIX PHARMACEUTICALS INC | c07238exv31w2.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Idenix Pharmaceuticals, Inc. (the
“Company”) for the quarter ended September 30, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), the
undersigned, Daniella Beckman, Interim Chief
Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350 as adopted
by Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: November 1, 2010
/s/
DANIELLA BECKMAN
|
||
Interim
Chief Financial Officer |
A signed original of this written statement required by Section 906 has been provided to Idenix
Pharmaceuticals, Inc. and will be retained by Idenix Pharmaceuticals, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.